Population Pharmacokinetics, Exposure–Response, and Probability of Target Attainment 1 Analyses for Tedizolid in Adolescent Patients With Acute Bacterial Skin and Skin
暂无分享,去创建一个
M. Rizk | P. Sears | C. Hardalo | Hwa-ping Feng | P. Sabato | M. Chou | Dan Li | B. Guiastrennec | A. Ouerdani | V. Duval | Natalya Broyde | C. D. Anda
[1] D. Sahm,et al. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe. , 2017, Diagnostic microbiology and infectious disease.
[2] D. Nicolau,et al. Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models , 2016, Antimicrobial Agents and Chemotherapy.
[3] E. Ludwig,et al. Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment , 2014, Antimicrobial Agents and Chemotherapy.
[4] Elaine Wong,et al. Tedizolid phosphate (sivextro): a second-generation oxazolidinone to treat acute bacterial skin and skin structure infections. , 2014, P & T : a peer-reviewed journal for formulary management.
[5] S. Flanagan,et al. Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid , 2014, Pharmacotherapy.
[6] G. Drusano,et al. Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] Anita F. Das,et al. Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. , 2013, JAMA.
[8] W. Craig,et al. Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model , 2012, Antimicrobial Agents and Chemotherapy.
[9] D. Nicolau,et al. Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers , 2012, Antimicrobial Agents and Chemotherapy.
[10] A. Louie,et al. Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model , 2011, Antimicrobial Agents and Chemotherapy.
[11] G. Drusano,et al. In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model , 2011, Antimicrobial Agents and Chemotherapy.
[12] G. Zurenko,et al. In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent , 2009, Antimicrobial Agents and Chemotherapy.
[13] J. Finn,et al. In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains , 2008, Antimicrobial Agents and Chemotherapy.